MedTrace Logo

Long Term Results of 450 Percutaneous Closures of PDA in a Single Center

NCT01929733 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2013-08-28

No results posted yet for this study

Summary

Percutaneous closure is one of the methods used to treat, among other congenital heart disorder, Persistent Ductus Arteriosus (PDA) in children and adults. During the years 1998-2013 four hundred and fifty patients were catheterized in the department of pediatric cardiology and congenital heart diseases in Rambam health care campus, using various devices.

In this retrospective research, the investigators analyze data from patients' medical files, to estimate and define the correlation between the patients' demographic and morphologic data to the type and size of chosen closure device.

Aim of study:

To create an algorithm that can be used to choose the proper device for percutaneous closure of the PDA, based on the characteristics of the patient and the PDA type.

Conditions

  • Patent Ductus Arteriosus

Sponsors & Collaborators

  • Rambam Health Care Campus

    lead OTHER

Principal Investigators

  • Moshe Dotan, MD · Rambam Health Care Campus

  • Omer Ephrat · Rambam Health Care Campus

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-01-31
Primary Completion
2013-08-31
Completion
2013-08-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01929733 on ClinicalTrials.gov